chr1-220796650-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022746.4(MTARC1):c.457G>A(p.Gly153Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,597,764 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022746.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MTARC1 | NM_022746.4 | c.457G>A | p.Gly153Ser | missense_variant | 3/7 | ENST00000366910.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MTARC1 | ENST00000366910.10 | c.457G>A | p.Gly153Ser | missense_variant | 3/7 | 1 | NM_022746.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000897 AC: 21AN: 234042Hom.: 0 AF XY: 0.0000708 AC XY: 9AN XY: 127194
GnomAD4 exome AF: 0.0000450 AC: 65AN: 1445444Hom.: 0 Cov.: 29 AF XY: 0.0000487 AC XY: 35AN XY: 719050
GnomAD4 genome AF: 0.000269 AC: 41AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 05, 2022 | The c.457G>A (p.G153S) alteration is located in exon 3 (coding exon 3) of the MARC1 gene. This alteration results from a G to A substitution at nucleotide position 457, causing the glycine (G) at amino acid position 153 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at